These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 6352305)

  • 1. The anti-allergic effect of the beta 2-adrenergic agent fenoterol in the nose.
    Borum P; Mygind N; Larsen FS
    Eur J Respir Dis Suppl; 1983; 128 (Pt 1)():44-9. PubMed ID: 6352305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluticasone propionate aqueous nasal spray reduces inflammatory cells in unchallenged allergic nasal mucosa: effects of single allergen challenge.
    Holm A; Dijkstra M; Kleinjan A; Severijnen LA; Boks S; Mulder P; Fokkens W
    J Allergy Clin Immunol; 2001 Apr; 107(4):627-33. PubMed ID: 11295650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The activity of recent anti-allergic drugs in the treatment of seasonal allergic rhinitis.
    Wang D; Clement P; Smitz J; De Waele M
    Acta Otorhinolaryngol Belg; 1996; 50(1):25-32. PubMed ID: 8669268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-allergic effect of beta-2 agonists and cholinoceptor antagonists in vitro.
    Morr H
    Eur J Respir Dis Suppl; 1983; 128 (Pt 1)():40-3. PubMed ID: 6193994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of seasonal allergen exposure on mucosal IL-16 and CD4+ cells in patients with allergic rhinitis.
    Pullerits T; Lindén A; Malmhäll C; Lötvall J
    Allergy; 2001 Sep; 56(9):871-7. PubMed ID: 11551252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a beta-adrenergic agonist, fenoterol, on nasal sensitivity to allergen.
    Schumacher MJ
    J Allergy Clin Immunol; 1980 Jul; 66(1):33-6. PubMed ID: 6103906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical trial design, nasal allergen challenge models, and considerations of relevance to pediatrics, nasal polyposis, and different classes of medication.
    Akerlund A; Andersson M; Leflein J; Lildholdt T; Mygind N
    J Allergy Clin Immunol; 2005 Mar; 115(3 Suppl 1):S460-82. PubMed ID: 15746883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of the immediate allergic reaction in the nose by the beta-2 adrenostimulant fenoterol.
    Borum P; Mygind N
    J Allergy Clin Immunol; 1980 Jul; 66(1):25-32. PubMed ID: 7381123
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of intra-nasal fenoterol solution on perennial allergic rhinitis.
    Yan K; Shaw J
    Eur J Respir Dis Suppl; 1983; 128 (Pt 2)():483-5. PubMed ID: 6352310
    [No Abstract]   [Full Text] [Related]  

  • 10. Do the leukotriene receptor antagonists work in children with grass pollen-induced allergic rhinitis?
    Keskin O; Alyamac E; Tuncer A; Dogan C; Adalioglu G; Sekerel BE
    Pediatr Allergy Immunol; 2006 Jun; 17(4):259-68. PubMed ID: 16771779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seasonal allergic rhinitis treated with a beta-2-adrenostimulant.
    Borum P; Larsen FS
    Allergy; 1987 Feb; 42(2):141-5. PubMed ID: 3035960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diminished response to grass pollen allergen challenge in subjects with concurrent house dust mite allergy.
    Reinartz SM; van Ree R; Versteeg SA; Zuidmeer L; van Drunen CM; Fokkens WJ
    Rhinology; 2009 Jun; 47(2):192-8. PubMed ID: 19593978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Protective effect of beta-adrenergic substances on the allergic rhinitis (author's transl)].
    Jorde W; Bohlmann HG; Linsenmann P; Werdermann K
    Med Klin; 1975 Aug; 70(32-33):1314-6. PubMed ID: 1226155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical treatment with aqueous solutions of rofleponide palmitate and budesonide in a pollen-season model of allergic rhinitis.
    Ahlström-Emanuelsson C; Andersson M; Persson C; Schrewelius C; Greiff L
    Clin Exp Allergy; 2004 May; 34(5):731-5. PubMed ID: 15144464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of intranasally applied dimethindene maleate solution as spray in adult volunteers with symptoms of seasonal allergic rhinitis in the Vienna challenge chamber.
    Kyrein HJ; Horak F; Nirnberger G; Rehn D
    Arzneimittelforschung; 1996 Aug; 46(8):794-9. PubMed ID: 9125281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased number of CD34+ cells in nasal mucosa of allergic rhinitis patients: inhibition by a local corticosteroid.
    Sergejeva S; Malmhäll C; Lötvall J; Pullerits T
    Clin Exp Allergy; 2005 Jan; 35(1):34-8. PubMed ID: 15649263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the drug monitoring programme of azelastine hydrochloride nasal spray in the treatment of allergic rhinitis in children under 13 years of age.
    Wober W; Diez Crespo CD; Bähre M
    Arzneimittelforschung; 1997 Jul; 47(7):841-4. PubMed ID: 9272242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of beclomethasone dipropionate treatment on the nasal provocation test.
    Clement PA; Kaufman L
    Rhinology; 1984 Sep; 22(3):183-91. PubMed ID: 6505518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in airway inflammation following nasal allergic challenge in patients with seasonal rhinitis.
    Bonay M; Neukirch C; Grandsaigne M; Leçon-Malas V; Ravaud P; Dehoux M; Aubier M
    Allergy; 2006 Jan; 61(1):111-8. PubMed ID: 16364165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Grass pollen immunotherapy: symptomatic improvement correlates with reductions in eosinophils and IL-5 mRNA expression in the nasal mucosa during the pollen season.
    Wilson DR; Nouri-Aria KT; Walker SM; Pajno GB; O'Brien F; Jacobson MR; Mackay IS; Durham SR
    J Allergy Clin Immunol; 2001 Jun; 107(6):971-6. PubMed ID: 11398073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.